COMMUNIQUÉS West-GlobeNewswire

-
Tonix Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational Highlights
09/11/2018 -
Fortress Biotech Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
09/11/2018 -
Wave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update
09/11/2018 -
TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2018 Financial Results
09/11/2018 -
Oxford Immunotec Reports Third Quarter 2018 Financial Results
09/11/2018 -
Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Meeting Showcasing Upregulation of PD-L1 Expression with Reovirus Infection
09/11/2018 -
Neos Therapeutics Reports Third Quarter 2018 Financial Results
09/11/2018 -
CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology
09/11/2018 -
VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
09/11/2018 -
Antares Pharma Announces Data Presentation at the 2018 Sexual Medicine Society Scientific Annual Meeting
09/11/2018 -
Axsome Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
09/11/2018 -
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress
09/11/2018 -
PLx Pharma Inc. Reports Third Quarter 2018 Results
09/11/2018 -
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018
09/11/2018 -
Mesoblast to Host Analyst Call on Results of End-Stage Heart Failure Trial Being Presented at 2018 American Heart Association Scientific Sessions
09/11/2018 -
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2018 Guidance Levels
09/11/2018 -
NASH clinical trial presentation and continued revenue growth
09/11/2018 -
AC Immune Shares Insights from Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases
09/11/2018 -
Rule 2.9 Announcement
09/11/2018
Pages